ResearchCotargeting DNA topoisomerase II enhances efficacy of RAS-targeted therapy in KRAS-mutant cancer models
ResearchSelective depletion of virus-specific CD8 T cells from the liver after PD-1 therapy with Fc-intact antibody during chronic infection
ResearchAdvancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer
ResearchInhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer
ResearchEarly detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent
ResearchBiomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data
ResearchParticipation in lung cancer biospecimen studies: an analysis of the ECOG-ACRIN phase 3 E1505 and E5508 clinical trials
ResearchA plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
ResearchELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib
ResearchPatient-reported outcomes from the LAURA study: osimertinib in patients with unresectable stage III EGFR-mutated non-small cell lung cancer after definitive chemoradiotherapy
Research"Protected time" for clinical investigators in medical oncology: The persistent gap between expectation and reality
ResearchClosing the Gap in Lung Cancer Outcomes-Medicaid Expansion for Communities With the Most to Gain
ResearchReal-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms